Overview Latest Regional Industry Featured Multimedia Other Languages Public Company News
Bloomage Debuts New Products at CPHI Milan to Reinforce Its Commitment to Innovation 2024-10-15 21:00
Neurophet-AriBio to develop 'Next-Gen Platform for Alzheimer's diagnosis' 2024-10-15 21:00
PharmAbcine Announces Safety Approval for 4mg Single-dose Cohort in Phase 1 Clinical Trial of PMC-403 for Neovascular Age-related Macular Degeneration 2024-10-15 09:51
Illuma, Global Pioneer in HMO Research, Launches Traceability Journey in Switzerland, Unveiling Next-Generation HMO Innovations 2024-10-14 23:31
Positive guidance from the U.S. FDA on 64Cu-SAR-bisPSMA Phase III trial in patients with recurrence of prostate cancer 2024-10-14 21:02
Tsingke Shines at Cell & Gene Therapy International 2024 2024-10-14 20:11
Samsung Biologics launches high-concentration formulation platform to accelerate high-dose drug development 2024-10-14 19:00
US FDA issues Study May Proceed letter for the Pilot Study of Pidnarulex Pharmacodynamics in Patients with Advanced Solid Tumors, Sponsored by the US National Cancer Institute 2024-10-14 19:00
Baird Medical to Participate in the American Thyroid Association (ATA) Annual Meeting 2024-10-14 17:00
BioCity will present the late-breaking clinical trial data of its ETA selective antagonist SC0062 at the American Society of Nephrology (ASN) 2024 with simultaneous publication of the trial data in the Journal of the American Society of Nephrology (JASN) 2024-10-14 15:38
21st TAITA Annual Conference Explores Taiwan's AI Era Strategies in the Global Tech Supply Chain 2024-10-14 10:32
Zhejiang Taimei Medical Technology Co., Ltd. Is Now Listed on HKEX 2024-10-14 10:18
Modern Meadow Appoints David Williamson as CEO 2024-10-14 09:00
Akeso Secures $250 Million USD to Propel Global Expansion of Its Innovative Drug Pipeline 2024-10-13 20:27
Sunvozertinib Granted Breakthrough Therapy Designation by China CDE for the First-Line Treatment of Non-Small Cell Lung Cancer with EGFR Exon 20 Insertion Mutations 2024-10-13 16:04
Ailux Biologics, a Division of XtalPi, Enters into a License Agreement with Janssen Biotech on Biologics AI Platform 2024-10-12 16:57
X3 Holdings Receives Extension to Regain Compliance with the Nasdaq's Minimum Bid Price Requirement 2024-10-12 04:30
Baird Medical Announces Preliminary Financial Results for the Six Months Ended June 30, 2024 2024-10-11 20:00
GenScript Biotech Advances Sustainable Development with MSCI ESG Rating Upgrade to A 2024-10-11 17:09
Waterdrop Inc. Released 2023 ESG Report: Adhere to both Sci-tech Innovation and Social Responsibility 2024-10-11 12:44
1 8 9 10 11 12 800